Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Rudy Saucillo who wrote (1275)	3/12/1998 7:25:00 PM
From: D.Right	Read Replies (2) \| Respond to of 2173

Dear Rudy: Is the publication available on the web? Thanks. D.Right

To: Rudy Saucillo who wrote (1275)	4/1/1998 8:12:00 AM
From: Ranger Rick	Respond to of 2173

Hi, I have been following since a while now both Ergo and Amln. Both are time sensitive as to delivery. I just read the hopefull importance here at AMLN on increasing the level of dosage in the new trails. At Ergo, the coctail type of time released phased in is noval, is there any hope here at AMLN of such a combination in order to increase efficiency-effiacy? At $3.00 ish here when must I check back to deterine when Euro trials will release more info. I wonder if that will dictate a new life here, and soon. Rick